Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 21.133% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: O=C(CSc1ccc2nnc(-c3cccnc3)n2n1)Nc1cccc(F)c1
b: CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CC1
Answer: b. CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CC1
CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CC1
(2S)-2-acetamido-N-cyclopropyl-3-(1H-indol-3-yl)propanamide